Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 6/20 | 0.43 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7048629 | 0.83 | NCF1 (0.55) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL28590788 | 0.82 | NCF1 (0.53) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL6034068 | 0.80 | HTT (0.50) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL13557874 | 0.77 | RAB9A (0.50) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL13557867 | 0.77 | KDM4E (0.47) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL31314983 | 0.77 | SMN1; SMN2 (0.39) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL28585105 | 0.74 | PDE10A (0.47) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL13557884 | 0.74 | RAB9A (0.48) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL28608866 | 0.73 | PDE10A (0.46) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL28679814 | 0.73 | KDM4E (0.45) | RAB9AKDM4ENPC1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | Rolic Technologies AG (CH) | 2024-06-11 | — | — | US | disclosed |
| CN-114026074-B | Novel polymerizable liquid crystal having quinoxaline-hydrazone nucleus | 罗利克技术有限公司 | 2024-02-09 | — | — | CN | disclosed |
| EP-3990568-B1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | ROLIC TECH AG (CH) | 2023-11-15 | — | — | EP | disclosed |
| US-20220251450-A1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | Rolic Technologies AG (CH) | 2022-08-11 | — | — | US | disclosed |
| EP-4022008-A1 | COMPOSITIONS OF POLYMERIZABLE LIQUID CRYSTALS | Rolic Technologies AG (CH) | 2022-07-06 | — | — | EP | disclosed |
| CN-114026074-A | Novel polymerizable liquid crystals with quinoxaline-hydrazone cores | 罗利克技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-20070238700-A1 | N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES | SCHERING-PLOUGH LTD. (CH) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | AQP1, AQP4, HCN1 | RAB9A 1201/4885KDM4E 2894/4885NPC1 3665/4885 |
| US-20070238700-A1 | N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES | NAT1, NGLY1, ELANE | RAB9A 831/4885KDM4E 1150/4885NPC1 313/4885 |
| US-20220251450-A1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | AQP1, AQP4, HCN1 | RAB9A 1175/4885KDM4E 2985/4885NPC1 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.